Skip to content

A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices

A Three-Month Clinical Study to Assess the Gingivitis Effects of Various Dentifrices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06140771
Enrollment
115
Registered
2023-11-20
Start date
2021-10-20
Completion date
2022-02-06
Last updated
2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Brief summary

The objective of this learning clinical study is to assess the gingivitis effects of four different dentifrices over a 3-month period.

Interventions

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

DRUG1.15% Sodium Monofluorophosphate Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be at least 18 years of age; * Provide written informed consent prior to participation and be given a signed copy of the informed consent form; * Be in general good health as determined by the Investigator based on a review of the health history/update for participation in the trial; * Have at least 16 gradable teeth; * Have mild to moderate gingivitis with a range of 10% to 70% bleeding sites; * Agree to return for scheduled visits and follow the study procedures; * Agree to refrain from use of any non-study oral hygiene products for the duration of the study; * Agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study.

Exclusion criteria

* Having taken antibiotic, anti-inflammatory, or anti-coagulant medications within 4 weeks of the Baseline Visit; * Have any oral conditions that could interfere with study compliance and/or examination procedures, such as widespread caries, soft or hard tissue tumor of the oral cavity, or advanced periodontal disease; * Removable oral appliances; * Fixed facial or lingual orthodontic appliances; * Self-reported pregnancy or lactation; * Any diseases or condition that might interfere with the safe participation in the study; and * Inability to undergo study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Löe-Silness Gingivitis Evaluation3 MonthsLöe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).

Secondary

MeasureTime frameDescription
Löe-Silness Gingivitis EvaluationBaselineLöe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026